 CAMBRIDGE, Mass., Sept. 22, 2021 PRNewswire -- Synlogic Nasdaq: SYBX, a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that it has commenced an underwritten public offering of its common stock. 